Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Keywords:
Materias Investigacion::Ciencias de la Salud
Colorrectal cancer
Publisher:
Nature Publishing Group
Note:
This article is licensed under a Creative Commons Attribution 4.0 International License.
The original version of this article contained an error in the spelling of the author P. Garcia-Alfonso, which was incorrectly given as P. Garcia.
Citation:
Borrero-Palacios, A. (A.); Cebrián, A. (A.); García-Carbonero, R. (R.); et al. "Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer". Scientific Reports. 9 (1), 2019, 2589
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.